Bonazoll 5 mg Solution For Infusion
PDF Leaflet Revision Date: 29 Aug 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of osteoporosis and Paget's disease.
Dosage (summary)
5 mg IV infusion once a year; hydration required prior to administration.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Caution with nephrotoxic drugs
- Avoid calcium-containing solutions
Contraindications
- Hypersensitivity
- Hypocalcaemia
- Severe renal impairment
Common side effects
- Pyrexia
- Myalgia
- Headache
- Nausea
- Arthralgia
Counselling Points
- Ensure adequate hydration
- Monitor for hypocalcaemia symptoms
- Maintain good oral hygiene
Serious warnings
- Risk of renal impairment
- Osteonecrosis of the jaw
- Atypical femur fractures
Important Disclaimer
The Bonazoll 5 mg Solution For Infusion professional information leaflet below is the property of Lnnovata Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
